Provided by Tiger Fintech (Singapore) Pte. Ltd.

Heartbeam Inc

1.42
-0.0600-4.05%
Pre-market: 1.490.0667+4.70%08:00 EDT
Volume:108.55K
Turnover:155.15K
Market Cap:48.01M
PE:-1.93
High:1.48
Open:1.48
Low:1.40
Close:1.48
Loading ...

HeartBeam (NASDAQ: BEAT) Earns FDA Clearance for First Cable-Free ECG System for Arrhythmia Detection

TIPRANKS
·
20 Jun

HeartBeam (NASDAQ: BEAT) Secures Two New Patents Advancing 3D ECG and Cardiac Monitoring Technology

TIPRANKS
·
19 Jun

HeartBeam (NASDAQ: BEAT) Is ‘One to Watch’

TIPRANKS
·
18 Jun

HeartBeam Inc. to Present at iAccess Alpha Virtual Best Ideas Summer Conference

Reuters
·
17 Jun

HeartBeam (NASDAQ: BEAT) VALID-ECG Study Confirms Diagnostic Accuracy of Synthesized 12-Lead ECG

TIPRANKS
·
16 Jun

HeartBeam’s Positive Earnings Call Reflects Growth Potential

TIPRANKS
·
16 May

Heartbeam Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
14 May

HeartBeam Q1 EPS $(0.18) Misses $(0.15) Estimate

Benzinga
·
14 May

BRIEF-HeartBeam Q1 Basic EPS USD -0.18

Reuters
·
14 May

HeartBeam Inc. Achieves Clinical Success with 93.4% Diagnostic Agreement in VALID-ECG Study, Advances Toward Commercial Readiness

Reuters
·
14 May

Heartbeam Inc expected to post a loss of 15 cents a share - Earnings Preview

Reuters
·
10 May

Heartbeam Announces Two New U.S. Patents, Powering Forward Its Robust Patent Portfolio

THOMSON REUTERS
·
06 May

HeartBeam Appoints CEO Robert Eno to Board

TIPRANKS
·
05 May

HeartBeam appoints CEO Robert Eno to board

TIPRANKS
·
05 May

Heartbeam Appoints CEO Robert Eno to Board of Directors to Support U.S. Commercialization and Growth

THOMSON REUTERS
·
05 May

Press Release: HeartBeam to Host First Quarter 2025 Results Conference Call on Tuesday, May 13, 2025 at 4:30 p.m. Eastern Time

Dow Jones
·
01 May

HeartBeam Inc. to Release First Quarter 2025 Results

Reuters
·
01 May

BRIEF-Heartbeam Successfully Meets Clinical Endpoints In Pivotal Study For Its Groundbreaking 12-Lead ECG Synthesis Technology

Reuters
·
29 Apr

Heartbeam Successfully Meets Clinical Endpoints in Pivotal Study for Its Groundbreaking 12-Lead Ecg Synthesis Technology

THOMSON REUTERS
·
29 Apr

HeartBeam Successfully Meets Clinical Endpoints in Pivotal Study for its Groundbreaking 12-Lead ECG Synthesis Technology

Business Wire
·
29 Apr